RE:RE:Deal or no deal!I think a buyout at ANY price is many months away. ONCY is just not behaving like a company seeking a buyout. They are behaving much more like a company raising money to get through the next year or so.
1. They just did a $15 million private placement at a price much lower than the closing price at that time. This, predictably, tanked our SP. There was no effort to support existing shareholders here. This could have been a rationalization that the shareholders (including ONCY mgmt personnel and BOD) will be rewarded once they get FDA approval for Pela.
2. They accepted a $5 million grant from PANCAN for an add-on trial. I doubt that PANCAN would have granted this money if a buyout was imminent or even in consideration. At the least, I'm guessing that PANCAN has a clause in the grant agreement that ONCY has to pay back some or all of that money if there is an acquisition within a specified time.
3. The trial results over the past few years has been good enough that ONCY would have been the target of DD efforts and likely acquisition offers by one or more BP companies. That nothing has transpired looks to me like ONCY have just not considered any offer worth considering. Or they have decided that their personal end prospects are better by not being acquired.
4. The continuing PR releases by FN Media Group are designed to attract potential new shareholders. This fits in with and supports ONCY's other fundraising methodology (ATM sales).
My working hypothesis is that ONCY is hoping to do the Precision Promise Phase III trial without benefit of a BP buyout. And we'll see a Phase III mBC trial only if and when Pela is approved for PDAC. I wish it were otherwise (I'd prefer a buyout myself), but I'm reading between the lines here.